Encellin
Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.
1
Funding Rounds
$5.9m
Money raised
Overview
Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Encellin has raised a total of $5.9m in funding over 1 rounds.
Key Insights:
- Encellin Seed round, August 2021: $5.9m
Encellin Seed round, August 2021
$5.9m
Industries
Encellin is active in the following industries: